World's Best Scientists 2026 revealed!
Chun-Shiang Chung

Chun-Shiang Chung

D-Index & Metrics

Immunology

D-Index
56
Citations
10317
World Ranking
3742
National Ranking
1718

Chun-Shiang Chung publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Chun-Shiang Chung sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 206 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Chun-Shiang Chung D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Chun-Shiang Chung sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Chun-Shiang Chung is affiliated with Brown University in the United States and conducts research primarily in the fields of Immunology and Microbiology, with significant work also relevant to Medicine. Their research spans several subfields including Immunology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, and Public Health, Environmental and Occupational Health.

The main topics addressed in their work include Immune Response and Inflammation, Immune Cell Function and Interaction, Immune cells in cancer, Sepsis Diagnosis and Treatment, Respiratory Support and Mechanisms, Inflammation biomarkers and pathways, and Neonatal and Maternal Infections.

Frequent publication venues for Chung include Frontiers in Immunology, Shock, Frontiers in Medicine, Journal of Surgical Research, and Research Square. These venues are reflective of the biomedical and clinical focus areas of their research.

  • Blockade of endothelial, but not epithelial, cell expression of PD-L1 following severe shock attenuates the development of indirect acute lung injury in mice (2020) - American Journal of Physiology-Lung Cellular and Molecular Physiology
  • Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics (2020) - Frontiers in Immunology
  • SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model (2020) - Molecular Medicine
  • Negative Immune Checkpoint Protein, VISTA, Regulates the CD4+ Treg Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival (2022) - Frontiers in Immunology
  • A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis (2020) - Shock

Chung has collaborated frequently with multiple coauthors including Alfred Ayala, Jihong Jiang, Yaping Chen, Chyna C. Gray, and Daithi S. Heffernan. These collaborations reflect sustained research partnerships within the immunology and sepsis research communities.

Best Publications

  • MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis

    Matthew J Delano;Philip O. Scumpia;Jason S. Weinstein;Dominique Coco

  • PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis

    Xin Huang;Fabienne Venet;Yvonne L. Wang;Alain Lepape

  • Leukocyte apoptosis and its significance in sepsis and shock.

    Doreen E. Wesche;Joanne L. Lomas-Neira;Mario Perl;Chun-Shiang Chung

  • Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients.

    Fabienne Venet;Chun-Shiang Chung;Hakim Kherouf;Anne Geeraert

  • Regulatory T cell populations in sepsis and trauma.

    Fabienne Venet;Chun-Shiang Chung;Guillaume Monneret;Xin Huang

  • In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice

    Doreen E. Wesche-Soldato;Chun-Shiang Chung;Chun-Shiang Chung;Joanne Lomas-Neira;Joanne Lomas-Neira;Lesley A. Doughty;Lesley A. Doughty

  • Pathogenesis of indirect (secondary) acute lung injury

    Mario Perl;Joanne Lomas-Neira;Fabienne Venet;Chun-Shiang Chung

  • Fas-induced Pulmonary Apoptosis and Inflammation during Indirect Acute Lung Injury

    Mario Perl;Chun-Shiang Chung;Ulrike Perl;Joanne Lomas-Neira

  • EARLY RENAL ISCHEMIA, WITH OR WITHOUT REPERFUSION, ACTIVATES NFκB AND INCREASES TNF-α BIOACTIVITY IN THE KIDNEY

    Kirstan K. Donnahoo;Daniel R. Meldrum;Robert Shenkar;Chun-Shiang Chung

  • The apoptotic pathway as a therapeutic target in sepsis.

    Doreen E. Wesche-Soldato;Ryan Z. Swan;Chun-Shiang Chung;Alfred Ayala

  • Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency.

    Alfred Ayala;Chun-Shiang Chung;Joanne L. Lomas;Grace Y. Song

  • Silencing of Fas, but Not Caspase-8, in Lung Epithelial Cells Ameliorates Pulmonary Apoptosis, Inflammation, and Neutrophil Influx after Hemorrhagic Shock and Sepsis

    Mario Perl;Chun-Shiang Chung;Joanne Lomas-Neira;Tina-Marie Rachel

  • Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge.

    Joanne Lomas-Neira;Chun-Shiang Chung;Mario Perl;Stephen Gregory

  • What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant?

    Grace Y. Song;Chun-Shiang Chung;Irshad H. Chaudry;Alfred Ayala

  • Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model

    Bethany M. Biron;Chun-Shiang Chung;Xian M. O'Brien;Yaping Chen

  • In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury

    Joanne L. Lomas-Neira;Chun-Shiang Chung;Doreen E. Wesche;Mario Perl

  • The Contribution of CD4+CD25+ T-Regulatory-Cells to Immune Suppression in Sepsis

    Nicholas Wisnoski;Chun-Shiang Chung;Yaping Chen;Xin Huang

  • Shock and hemorrhage: an overview of animal models.

    J L Lomas-Niera;Mario Perl;Chun-Shiang Chung;Alfred Ayala

  • Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity

    Chung-Shiang Chung;Grace Y. Song;Joanne Lomas;H. Hank Simms

  • Lymphocytes in the Development of Lung Inflammation: A Role for Regulatory CD4+ T Cells in Indirect Pulmonary Lung Injury

    Fabienne Venet;Chun-Shiang Chung;Xin Huang;Joanne Lomas-Neira

  • Is Fas Ligand or Endotoxin Responsible for Mucosal Lymphocyte Apoptosis in Sepsis

    Chun-Shiang Chung;Ying Xin Xu;Weiyang Wang;Irshad H. Chaudry

Frequent Co-Authors

Alfred Ayala
Alfred Ayala Brown University
William G. Cioffi
William G. Cioffi Brown University
Fabienne Venet
Fabienne Venet Claude Bernard University Lyon 1
Irshad H. Chaudry
Irshad H. Chaudry University of Alabama at Birmingham
Guillaume Monneret
Guillaume Monneret Hôpital Édouard-Herriot
Jonathan S. Reichner
Jonathan S. Reichner Brown University
Walter L. Biffl
Walter L. Biffl University of California, Irvine
Lyle L. Moldawer
Lyle L. Moldawer University of Florida
Reuben Ramphal
Reuben Ramphal University of Florida
John E. McGeary
John E. McGeary Brown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open up diverse career opportunities in healthcare and research. Many professionals pivot towards nursing fields, which complement immunology knowledge with practical patient care skills. For example, an accelerated FNP program offers a fast track to becoming a Family Nurse Practitioner, blending clinical expertise with leadership roles in patient immune health management.

Individuals without a nursing background can enter the field through accessible options like online ADN programs for non nurses. These programs provide essential foundational skills and fast-track pathways into nursing roles, making them ideal for those seeking a career shift.

Accelerated programs such as accelerated BSN programs for non nurses are also popular. They offer an efficient route to earning a Bachelor of Science in Nursing, equipping students with rigorous training crucial for careers in immunology-related settings.

Additionally, starting with practical roles through best easiest LPN programs to get into can provide valuable hands-on experience. Licensed Practical Nurse programs are often more accessible and can serve as stepping stones toward advanced immunology-focused healthcare careers.

Best Scientists Citing Chun-Shiang Chung

Trending Scientists